(Canavan Disease)(Gene Therapy)(Press Release)
Alicia has over 20 years of industry experience including the operation of a successful regulatory and clinical development consulting practice working with several small to large biotech and pharma companies across several therapeutic areas with a specialization in rare diseases, leadership of several successful marketing applications and approvals, and has held full-time positions with increasing responsibility at Eli Lilly, EMD Serono, Alexion, and Rhythm Pharmaceuticals.
(Canavan Disease)(Gene Therapy)(Press Release)
(Gene Therapy)
(Gene Therapy)(Q & A)